Study: Methadone and Buprenorphine Aren’t Used Enough in Opioid Recovery

buy endocet online usa

BOSOTN, MA - APRIL 27: A patient displays his Suboxone prescription following his appointment at the Substance Use Disorders Bridge Clinic at Massachusetts General Hospital in Boston on April 27, 2018. The patient takes Suboxone, a medicine that contains buprenorphine and naloxone, to treat his substance use disorder. He said he had been addicted to Opioids for 10 years but has been drug free since he started taking Suboxone nearly 2 years ago. (Photo by Craig F. Walker/The Boston Globe via Getty Images)

Buy Endocet Online USA Just 12.5% of patients with opioid use disorder were treated with buprenorphine or methadone in recent years, according to the new study.(CRAIG F. WALKER/THE BOSTON GLOBE/GETTY IMAGES)

FAR TOO FEW PEOPLE WITH opioid addiction have had access to the most effective treatments in recent years, a new study suggests.

Furthermore Getting people into high-quality, evidence-based addiction treatment is seen as key to curbing the nation’s deadly opioid epidemic. The new study, published Wednesday in JAMA Network Open, indicates that treatment using buprenorphine or methadone – medications that can help people manage opioid withdrawal – is by far the most effective way to prevent overdoses and hospitalizations, but that people were much less likely to have access to these medications than to other treatments. Buy Endocet Online USA

Furthermore the analysis included nearly 41,000 people with opioid use disorder who had commercial.

health insurance or Medicare Advantage plans from approximately 2015 to 2017 – three years when nearly 123,000 .

people died of opioid overdoses. Furthermore  The study find that just 12.5% of patients are treat with buprenorphine or methadone, compared with 59.3% who receive outpatient counseling only and 15.8% who go into residential rehabilitation or detox services.

“We’ve known for years that methadone and buprenorphine are the most effective treatments.

So we have for opioid use disorder,” says Dr. Sarah Wakeman, the study’s lead author and medical director of Massachusetts General Hospital‘s substance use disorders initiative.”I think there’s been a real gap between what science has shown us is most effective and then what actually.

happens in real-world clinical practice.”

Leave a Reply

Your email address will not be published. Required fields are marked *